152 related articles for article (PubMed ID: 27228559)
1. Racial disparities in renal cell carcinoma: a single-payer healthcare experience.
Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B
Cancer Med; 2016 Aug; 5(8):2101-8. PubMed ID: 27228559
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
[TBL] [Abstract][Full Text] [Related]
3. Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system.
Suarez-Sarmiento A; Yao X; Hofmann JN; Syed JS; Zhao WK; Purdue MP; Chow WH; Corley D; Shuch B
Int J Urol; 2017 Oct; 24(10):765-770. PubMed ID: 28913849
[TBL] [Abstract][Full Text] [Related]
4. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
Patel HD; Kates M; Pierorazio PM; Allaf ME
Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
[TBL] [Abstract][Full Text] [Related]
5. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.
Callahan CL; Schwartz K; Corley DA; Ruterbusch JJ; Zhao WK; Shuch B; Graubard BI; Rothman N; Chow WH; Silverman DT; Purdue MP; Hofmann JN
Cancer Causes Control; 2020 Jan; 31(1):85-93. PubMed ID: 31782041
[TBL] [Abstract][Full Text] [Related]
6. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
[TBL] [Abstract][Full Text] [Related]
7. Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma.
Alam R; Rezaee ME; Pallauf M; Elias R; Yerrapragada A; Enikeev D; Fang D; Shariat SF; Woldu SL; Ged YMA; Singla N
Urol Oncol; 2023 Nov; 41(11):460.e1-460.e9. PubMed ID: 37709565
[TBL] [Abstract][Full Text] [Related]
8. Black race may be associated with worse overall survival in renal cell carcinoma patients.
Anastos H; Martini A; Waingankar N; Paulucci DJ; Beksac AT; Daza J; Patel HV; Gin GE; Sfakianos JP; Badani KK
Urol Oncol; 2020 Dec; 38(12):938.e9-938.e17. PubMed ID: 32950398
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
Rose TL; Deal AM; Krishnan B; Nielsen ME; Smith AB; Kim WY; Milowsky MI
Cancer; 2016 Oct; 122(19):2988-95. PubMed ID: 27341404
[TBL] [Abstract][Full Text] [Related]
10. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
Chow WH; Shuch B; Linehan WM; Devesa SS
Cancer; 2013 Jan; 119(2):388-94. PubMed ID: 23147245
[TBL] [Abstract][Full Text] [Related]
11. Race and renal cell carcinoma stage at diagnosis: an analysis of the Surveillance, Epidemiology, and End Results data.
Lin J; Kamamia C; Shriver CD; Zhu K
Eur J Cancer Prev; 2019 Jul; 28(4):350-354. PubMed ID: 30376467
[TBL] [Abstract][Full Text] [Related]
12. Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
Sung JM; Martin JW; Jefferson FA; Sidhom DA; Piranviseh K; Huang M; Nguyen N; Chang J; Ziogas A; Anton-Culver H; Youssef RF
Clin Genitourin Cancer; 2019 Oct; 17(5):e995-e1002. PubMed ID: 31239240
[TBL] [Abstract][Full Text] [Related]
13. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
14. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
[TBL] [Abstract][Full Text] [Related]
15. Survival among Black and White patients with renal cell carcinoma in an equal-access health care system.
Lin J; Zahm SH; Shriver CD; Purdue M; McGlynn KA; Zhu K
Cancer Causes Control; 2015 Jul; 26(7):1019-26. PubMed ID: 25956269
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer.
Krimphove MJ; Cole AP; Fletcher SA; Harmouch SS; Berg S; Lipsitz SR; Sun M; Nabi J; Nguyen PL; Hu JC; Kibel AS; Choueiri TK; Kluth LA; Trinh QD
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):125-136. PubMed ID: 30171227
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma in patients with end-stage renal disease is associated with more favourable histological features and prognosis.
Chen K; Huang HH; Aydin H; Tan YH; Lau WK; Cheng CW; Yuen JS
Scand J Urol; 2015 Jun; 49(3):200-4. PubMed ID: 25783025
[TBL] [Abstract][Full Text] [Related]
18. The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma.
Rampersaud EN; Klatte T; Bass G; Patard JJ; Bensaleh K; Böhm M; Allhoff EP; Cindolo L; De La Taille A; Mejean A; Soulie M; Bellec L; Christophe Bernhard J; Pfister C; Colombel M; Belldegrun AS; Pantuck AJ; George D
Urol Oncol; 2014 Jan; 32(1):30.e9-13. PubMed ID: 23422777
[TBL] [Abstract][Full Text] [Related]
19. BAP1 is overexpressed in black compared with white patients with Mx-M1 clear cell renal cell carcinoma: A report from the cancer genome atlas.
Paulucci DJ; Sfakianos JP; Yadav SS; Badani KK
Urol Oncol; 2016 Jun; 34(6):259.e9-259.e14. PubMed ID: 26854086
[TBL] [Abstract][Full Text] [Related]
20. Associations of Renal Cell Carcinoma Subtype with Patient Demographics, Comorbidities, and Neighborhood Socioeconomic Status in the California Population.
Lichtensztajn DY; Hofer BM; Leppert JT; Brooks JD; Chung BI; Shah SA; DeRouen MC; Cheng I
Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):202-207. PubMed ID: 36480301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
